Navigation Links
Discovery Could Lead To Novel Approaches In HIV Treatment

CANVAC, the Canadian Network for Vaccines and Immunotherapeutics, has announced the development of a new method to assess how well the thymus (an organ located at the base of the neck) works and the discovery of a functional abnormality of this organ in HIV-infected individuals. The team of investigators led by Dr. Rafick-Pierre Sékaly, professor at Université de Montréal, scientist at the CHUM Research Centre, and Scientific Director and Program Leader of CANVAC, publishes today its discoveries in Immunity, a prestigious scientific journal. This work was performed in collaboration with investigators from the Research Institute of the McGill University Health Centre as well as from France and Israel.

Using only blood samples, these researchers first developed a method to assess how well the thymus functions. The thymus is involved in the development of T-lymphocytes, an essential component of the immune system. T-lymphocytes also happen to be HIV's preferred targets for infection. The researchers then used this method to study blood samples from patients that had been recently infected with HIV and found that, already in the first months following the onset of infection, thymic function is decreased. Such a decrease results in a lowered T-lymphocyte production by the thymus. These findings pave the way to the development of novel immunotherapies of HIV-infected individuals. Such immunotherapies could be also applicable to patients requiring bone marrow transplantation to cure their cancer.
'"/>

Source:CANVAC press release


Page: 1

Related biology news :

1. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
2. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
3. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
4. Discovery Promises Simpler Therapy for Sickle Cell Disease
5. Discovery may lead to better Candidiasis drug
6. Protein Discovery Could Unlock The Secret To Better TB Treatment
7. Discovery clarifies role of peptide in biological clock
8. Eliminate Data Analysis Bottlenecks in Drug Discovery
9. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
10. Discovery could be key to bioterrorism defense
11. Discovery of an American salamander where it shouldnt be: Korea

Post Your Comments:
(Date:11/6/2009)...ersary this month of the publication of On the Ori...al Sciences (AIBS) is publishing open access two p... historic insights into evolution. , The two arti...fornia, Berkeley, and James T. Costa of Western Ca...out Charles Darwin," appeared in the October issue...
(Date:11/5/2009)...at Yale University have developed synthetic molecu...e to HIV and HIV-infected cells, as well as to pro...ne in the Journal of the American Chemical Societ... these diseases. , The molecules called "antib... "antibody-recruiting molecule targeting prostate ...
(Date:11/4/2009)...009 Childhood obesity in the United States is rea...rth of advertising on daytime and prime time telev...g questions about the role television plays in obe...e Journal of Nutrition Education and Behavior ex...t be a large contributor to the problem. , Resea...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Step forward for nanotechnology 3A Controlled movement of molecules 10184 1Doctors May Be Able to Predict Domestic Abuse 58545 1Doctors May Be Able to Predict Domestic Abuse 58545 2UCSF Announces Expanded BreastCancerTrials org Website 58543 1UCSF Announces Expanded BreastCancerTrials org Website 58543 2UCSF Announces Expanded BreastCancerTrials org Website 58543 3UCSF Announces Expanded BreastCancerTrials org Website 58543 4UCSF Announces Expanded BreastCancerTrials org Website 58543 5UCSF Announces Expanded BreastCancerTrials org Website 58543 6
...oxide (CO2) emissions is far outpacing previous es...c greenhouse gases much more difficult, according ...of California, Berkeley, and UC San Diego. , Prev...overnmental Panel on Climate Change, say the regio...annual increase in CO2 emissions, the largest cont...
... Lab has shed new light on a novel histone acetylt...sferases are enzymes that introduce a new acetyl f...y which all chromosome functions are controlled. ...ture Structural and Molecular Biology yesterday an...rnal. , ATAC is unique as the only acetyltransf...
...belief, Anatolia was not geographically isolated 2...this has just been demonstrated by researchers fro...ologie (LMTG) (CNRS/ University of Toulouse 3/IRD)...oratory (CNRS/Musum national dhistoire naturelle/U... thanks to analyses of the first fossilized giant ...
Other Biology News:New UC analysis shows alarming increase in expected growth of China's carbon dioxide emissions 2New UC analysis shows alarming increase in expected growth of China's carbon dioxide emissions 3Workman Lab characterizes novel regulator of chromosome function 2A fossilized giant rhino bone questions the isolation of Anatolia, 25 million years ago 2
(Date:11/5/2009)... Nov. 5 The endangered black-foote... U.S. This rare carnivore feeds on prairie dogs. ...and often entire population die-offs in towns occu... implemented a ferret breeding program and has bee...rmerly native habitat. Unfortunately, plague can ...
(Date:11/5/2009)... Thursday, November 5, 2009 at 4:30 p.m. Eastern T...swire-FirstCall/ - OncoGenex Pharmaceuticals, Inc....oday reported unaudited financial results for the ...2009 and reviewed the Company,s highlights for the...idated results reflect the operations of OncoGenex...
(Date:11/5/2009)... Nov. 5 Wound Management...it has entered into a Letter of Intent to purchase...echnologies, Inc. (OTC Bulletin Board: VHGI). The ...sh and debt, 4,000,000 shares of WNDM and a royalt...Veriscrip technology being acquired from VHGI. W...
(Date:11/5/2009)...NG, Pa., Nov. 5 /PRNewswire-Asia-FirstCall/ -- BMP...one" or the "Company") today announced,that the Co...l results on,Monday, November 9, 2009, after the m...onference call at 5:00 pm ET on November 9, 2009,t...ay access the call by,dialing 1-888-713-4211 or 1-...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...yte Genetics,Corporation,s (CellCyte) (OTC Bulleti...ll present at the 2008 San Francisco RedChip Small...0:35 AM Pacific Daylight Time at the,Palace Hotel ...a booth at,the conference at which they will have ...pansion bioreactor., The presentation will be Web...
...lan designed to develop,educational opportunities ...d the Tiger Woods Learning Center (TWLC) are colla...cation. "A recent report by the National,Research ...and argued that,students are more likely to have i...participate in hands-on experiences," says Jeff Ha...
...nse to numerous,shareholder questions, CEL-SCI COR...he construction of its manufacturing facility near...t out, will comprise 73,000 square,feet and will b...lead,cancer product. This dedicated facility will ...I,s pivotal Phase III clinical trial for first-lin...
Other Biology Technology:LI-COR(R) Biosciences and Tiger Woods Learning Center Collaborate to Develop High School Curriculum in Genetics 2CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter 2CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter 3
Mouse Anti-Human Thyroid Hormone Rec., alpha1 / alpha2-Isotype Antibody, Unconjugated from ABR-Affinity BioReagents
Custom DNA Primers from Invitrogen
Acrylamide from GE Healthcare, formerly Amersham Biosciences
Direct ELISA Assay Diluent - EDTA from BioFX Laboratories, Inc.
Biology Products: